The U.S. Tariff Landscape and Its Implications The recent implementation of tariffs by the United States on imported pharmaceuticals has raised questions about its impact on India’s robust pharmaceutical sector. Rajiv Nannapaneni, CEO of Natco Pharma, emphasized that despite these tariffs, the Indian pharmaceutical industry is unlikely to face significant adverse effects. With 92% of…